Mirabegron Trade Names
Mirabegron is marketed under the trade names Myrbetriq (USA), Betmiga (EU), and Betanis (Japan). 1
Regional Brand Names
Available Formulations
- Extended-release tablets: Available for adults and pediatric patients weighing ≥35 kg 2
- Extended-release oral suspension (Myrbetriq Granules): Specifically formulated for pediatric patients, particularly those weighing <35 kg 2
Important note: The ER tablet and ER oral suspension formulations are not substitutable on a mg-by-mg basis. 2